On March 3, 2023, several clinicians and staff members from the Department of Anesthesiology presented at the 13th Annual Patient Safety & Quality Symposium.
WashU anesthesiologists present at Annual Patient Safety & Quality Symposium
Category: Research
Department ranks in top 3 in NIH research funding in 2022
According to the latest data compiled by the Blue Ridge Institute for Medical Research, the Department of Anesthesiology at Washington University School of Medicine in St. Louis ranked No. 3 among the nation’s top anesthesiology departments in terms of research funding from the National Institutes of Health (NIH).
WashU Medicine reaches new heights as it climbs to No. 3 in NIH research funding (Links to an external site)
Scientists at Washington University School of Medicine in St. Louis were awarded $569 million in research grants from the National Institutes of Health (NIH) in federal fiscal year 2022, elevating WashU to No. 3 among U.S. medical schools in total NIH research funding support.
Brandon Tan, MD, selected as 2023 Dean’s Scholar
Brandon Tan, MD, PGY5 and an ASAP trainee, has been selected as one of the 2023 Dean’s Scholars. His project explores how the serotonin 3 receptor—implicated in nausea, depression, anxiety, and psychosis—changes its activity when the lipid environment is altered.
Burel R. Goodin, PhD, to join Department of Anesthesiology
The Department of Anesthesiology is delighted to announce that Burel R. Goodin, PhD, is joining Washington University School of Medicine as professor of anesthesiology March 1, 2023.
WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive (Links to an external site)
A research team, led by scientists at the Center for Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences & Pharmacy in St. Louis, have altered the chemical properties of fentanyl and the way that it binds to opioid receptors on nerve cells. The goal is to improve the drug’s safety profile without eliminating its ability to alleviate pain.
Majumdar Featured in Nature Chemical Biology (Links to an external site)
The paper highlights the work of Susruta Majumdar, Ph.D., associate professor of medicinal chemistry and pharmacology at University of Health Sciences and Pharmacy in St. Louis, and his colleagues who examined the molecular differences between LFT and MP, and how they bind to MU opioid receptors.
Study elucidates mechanism of lipid regulation of ion channels
In a recent study published in Nature Communications on November 17, 2022, Wayland Cheng, MD, PhD, and colleagues solved the structure of a pentameric ligand-gated ion channel in an open-channel conformation using single particle cryo-electron microscopy.
Understanding, treating pain, reducing opioid use, aim of $11.7 million grant (Links to an external site)
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to identify new ways to treat it.
Kannampallil named inaugural director of acute care innovation research
Dr. Kannampallil will plan, direct, and coordinate research activities related to technology, telemedicine, and innovation within the department. He will also provide population, organizational, and patient-level data, analysis and decision support to advance innovative and technology-related initiatives for the department.